{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:42:15Z","timestamp":1791049335073,"version":"4.1.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053345","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T17:07:55Z","timestamp":1359479275000},"page":"e53345","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Stimulating \u03b2-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor"],"prefix":"10.1371","volume":"8","author":[{"family":"Ansarullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Holstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"DeRuyter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Rabinovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1172\/JCI29103","article-title":"Islet beta cell failure in type 2 diabetes","volume":"116","author":"M Prentki","year":"2006","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/10.1210\/er.2006-0038","article-title":"beta-cell failure in diabetes and preservation by clinical treatment","volume":"28","author":"BL Wajchenberg","year":"2007","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.cell.2012.02.010","article-title":"Diabetes mellitus and the beta cell: the last ten years","volume":"148","author":"FM Ashcroft","year":"2012","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"DJ Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/en.2010-0115","article-title":"Minireview: update on incretin biology: focus on glucagon-like peptide-1","volume":"151","author":"PL Brubaker","year":"2010","journal-title":"Endocrinology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1463-1326.2007.00705.x","article-title":"Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug","volume":"9","author":"I Idris","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc07-0228","article-title":"Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action","volume":"30","author":"DJ Drucker","year":"2007","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1185\/030079908X261069","article-title":"Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials","volume":"24","author":"A Karasik","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrd2245","article-title":"Sitagliptin","volume":"6","author":"D Drucker","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1007\/s00125-006-0416-z","article-title":"Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus","volume":"49","author":"I Raz","year":"2006","journal-title":"Diabetologia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MED.0b013e3280a02f65","article-title":"Dipeptidyl peptidase-4 inhibitors and the management of type 2 diabetes mellitus","volume":"14","author":"J Rosenstock","year":"2007","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/en.2007-0966","article-title":"A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release","volume":"149","author":"ZL Chu","year":"2008","journal-title":"Endocrinology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2004.11.120","article-title":"Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor","volume":"326","author":"T Soga","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/en.2006-1608","article-title":"A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release","volume":"148","author":"ZL Chu","year":"2007","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"HA Overton","year":"2006","journal-title":"Cell Metab"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1517\/13543770903153878","article-title":"GPR119 agonists for the treatment of type 2 diabetes","volume":"19","author":"RM Jones","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Gao J, Tian L, Weng G, Bhagroo NV, Sorenson RL, <etal>et al<\/etal>.. (2011) Stimulating beta cell replication and improving islet graft function by GPR119 agonists. Transpl Int.","DOI":"10.1111\/j.1432-2277.2011.01332.x"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/0091270006289850","article-title":"Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects","volume":"46","author":"GA Herman","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1210\/jc.2006-1009","article-title":"Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes","volume":"91","author":"GA Herman","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1210\/en.2010-0068","article-title":"Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor","volume":"151","author":"L Tian","year":"2010","journal-title":"Endocrinology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.1073\/pnas.0631828100","article-title":"Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance","volume":"100","author":"SL Conarello","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/db05-1602","article-title":"Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes","volume":"55","author":"J Mu","year":"2006","journal-title":"Diabetes"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.diabres.2010.10.012","article-title":"A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing beta-cell replication and neogenesis","volume":"91","author":"JM Cho","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1463-1326.2009.01180.x","article-title":"Chronic administration of DSP-7238, a novel, potent, specific and substrate-selective DPP IV inhibitor, improves glycaemic control and beta-cell damage in diabetic mice","volume":"12","author":"Y Furuta","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4161\/isl.3.6.17923","article-title":"Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic beta-cells","volume":"3","author":"SH Lee","year":"2011","journal-title":"Islets"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-543X.2004.00075.x","article-title":"The pancreatic ductal epithelium serves as a potential pool of progenitor cells","volume":"5","author":"S Bonner-Weir","year":"2004","journal-title":"Pediatr Diabetes"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.2337\/db06-1670","article-title":"Differentiation of affinity-purified human pancreatic duct cells to beta-cells","volume":"56","author":"S Yatoh","year":"2007","journal-title":"Diabetes"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MOT.0b013e3283344932","article-title":"Regenerating pancreatic beta-cells: plasticity of adult pancreatic cells and the feasibility of in-vivo neogenesis","volume":"15","author":"K Juhl","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"G Xu","year":"1999","journal-title":"Diabetes"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2337\/db08-1198","article-title":"Adaptive beta-cell proliferation is severely restricted with advanced age","volume":"58","author":"MM Rankin","year":"2009","journal-title":"Diabetes"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/db08-1651","article-title":"Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice","volume":"58","author":"SI Tschen","year":"2009","journal-title":"Diabetes"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-08-0596","article-title":"Impaired islet turnover in human donor pancreata with aging","volume":"160","author":"C Reers","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1210\/jc.2010-0932","article-title":"Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating","volume":"95","author":"S Perl","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/db09-1698","article-title":"Beta-cell replication is increased in donor organs from young patients after prolonged life support","volume":"59","author":"P In\u2019t Veld","year":"2010","journal-title":"Diabetes"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1432-2277.2011.01275.x","article-title":"Comparison of exendin-4 on beta-cell replication in mouse and human islet grafts","volume":"24","author":"L Tian","year":"2011","journal-title":"Transpl Int"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.2337\/diabetes.51.11.3229","article-title":"Glucagon is required for early insulin-positive differentiation in the developing mouse pancreas","volume":"51","author":"K Prasadan","year":"2002","journal-title":"Diabetes"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbrc.2006.10.076","article-title":"Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP-cells","volume":"351","author":"Y Sakamoto","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1677\/joe.0.1650093","article-title":"Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice","volume":"165","author":"Z Li","year":"2000","journal-title":"J Endocrinol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08894","article-title":"Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss","volume":"464","author":"F Thorel","year":"2010","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1242\/dev.01925","article-title":"Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates","volume":"132","author":"AL Means","year":"2005","journal-title":"Development"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-009-1390-z","article-title":"Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice","volume":"52","author":"WL Suarez-Pinzon","year":"2009","journal-title":"Diabetologia"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T20:53:31Z","timestamp":1562619211000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053345"}},"subtitle":[],"editor":[{"given":"Bridget","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053345","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]}}}